Corporate GovernanceJun 4, 2026, 08:56 AM
Park Ha Biological Elects Nasdaq Home Country Practice Exemptions
AI Summary
Park Ha Biological Technology Co., Ltd. has elected to rely on the Nasdaq home country practice exemption under Rule 5615(a)(3). As a company incorporated in the Cayman Islands, this allows it to follow its home country corporate governance practices in lieu of certain Nasdaq requirements. These exemptions include rules regarding the composition of the board of directors, distribution of reports, and shareholder approval for various securities issuances and changes to voting rights.
Key Highlights
- Elected to rely on Nasdaq Listing Rule 5615(a)(3) home country practice exemption.
- Exempted from Nasdaq Rule 5605(b)(1) requiring a majority of independent directors on the board.
- Exempted from Nasdaq Rule 5250(d) regarding the distribution of annual and interim reports.
- Exempted from Nasdaq Rule 5635(a), (b), (c), and (d) concerning shareholder approval for various securities issuances.
- Exempted from Nasdaq Rule 5640 which restricts disparately reducing or restricting voting rights.
- Cayman Islands counsel confirmed that these practices are not prohibited under home country law.
Price Impact
More from BYAH